SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
SOPHiA GENETICS SA (SOPH) Tops Q2 EPS by 8c
August 9, 2022 7:12 AM EDTSOPHiA GENETICS SA (NASDAQ: SOPH) reported Q2 EPS of ($0.31), $0.08 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $11.7 million versus the consensus estimate of $12.15 million.
For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.
... More


